Heart Donor Management and Expansion of Current Donor Selection Criteria

Journal of Heart and Lung Transplantation

Volumn 19, Issue 8, 2000, Pages

  Livi, U ^a,b   Caforio, A L P ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GRAFT SURVIVAL; HEART ARREST; HEART TRANSPLANTATION; HUMAN; ISCHEMIA; ORGAN DONOR; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SUDDEN INFANT DEATH SYNDROME;

ADULT; AGE FACTORS; AGED; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RISK ASSESSMENT; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; UNITED STATES;

EID: 4243484328     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1053-2498(00)00107-8     Document Type: Article

References (61)

1. Barnard CN. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 1967;41:1271-5.
2. D'Alessandro AM, Hoffman RM, Knechtle SJ, et al. Successful extrarenal transplantation from non-heart-beating donors. Transplantation 1995;59:977-82.
3. Gundry SR, deBegona JA, Kawauchi M, Bailey LL. Successful transplantation of hearts harvested 30 minutes after death from exsanguination. Ann Thorac Surg 1992;53:772-5.
4. Buckberg GD. Studies of controlled reperfusion after ischemia; 1. When is cardiac muscle damaged irreversibly? J Thorac Cardiovasc Surg 1986;92:483-7.
5. Dureau G. Heart transplant from non-beating heart donor. Past experience and report of one clinical case. In: Touraine JL, Traeger J, Betuel H, Dubernard JM, Revillard JP, Dupuy C, eds. Organ shortage: the solutions. Dordrecht: Kluwer Academic Publishers, 1995; pp. 61-6.
6. Bourge RC, Naftel DC, Costanzo-Nordin MR, et al. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1993;12:549-62.
7. Opelz G, Wujciak T, Collaborative Transplant Study. The influence of HLA compatibility on graft survival after heart transplantation. N Eng J Med 1994;330:816-9.
8. Young JB, Naftel DC, Bourge RC, et al. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. J Heart Lung Transplant 1994;13:353-65.
9. Briganti EM, Bergin PJ, Rosenfeldt FL, Esmore DS, Rabinov M. Successful long-term outcome with prolonged ischemic time cardiac allograft. J Heart Lung Transplant 1995; 14:840-5.
10. Kawauchi M, Gundry SR, deBegona JA, et al. Prolonged preservation of human pediatric hearts for transplantation: correlation of ischemic time and subsequent function. J Heart Lung Transplant 1993;12:55-8.
11. Wheeldon D, Sharples L, Wallwork J, English T. Donor heart preservation survey. J Heart Lung Transplant 1992;11: 986-93.
12. Obadia JF, Girard C, Ferrara R, Chuzel M, Chassignolle JF, Dureau G. Long conservation organs in heart transplantation: postoperative results and long-term follow-up in fourteen patients. J Heart Lung Transplant 1997;16:256-9.
13. Livi U, Caforio ALP, Guzzi G, et al. Impact of organ preservation techniques on outcome of cardiac transplantation in the era of donor pool expansion. Transplant Proc 1997 (in press).
14. Petri S, Culcasi M, Albat B, Alberici G, Menasche P. Direct assessment of the antioxidant effects of a new heart preservation solution, Celsior. Transplantation 1994;58:739-40.
15. 2+ overload in isolated perfused rabbit heart. Circulation 1994; 89:2787-98.
16. Masuda M, Chang-Chun C, Mollhoff T, Van Belle H, Flameng W. Effects of nucleoside transport inhibition on long-term ex vivo preservation of canine hearts. J Thorac Cardiovasc Surg 1992;104:1610-17.
17. Koyano T, Takashashi I, Takeyoshi Y, et al. The effects of FR167653 on ischemia-reperfusion injury of the canine heart. J Heart Lung Transplant 1997;16:60.
18. Cocanougher Ballantyne CM, Pollack MS, et al. Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant. Transplant Proc 1993;25:233-6.
19. Rose A, Novtizky D, Factor S. Catecholamine-associated smooth muscle contraction bands in the media of coronary arteries of brain-dead baboons. Am J Cardiovasc Pathol 1988;2:63-7.
20. Hendry PJ, Anstadt MP, Plunkett MD, et al. Optimal temperature for preservation of donor myocardium. Circulation 1990;82:306-12.
21. Pearl J, Drinkwater D, Laks H, et al. Leucocyte-depleted reperfusion of transplanted human hearts: a randomized double-blind clinical trial. J Heart Lung Transplant 1992;11: 1082-92.
22. Hauptman PJ, Davis SF, Miller L, Yeung AC, Multicenter Intravascular Ultrasound Transplant Study Group. The role of nonimmune risk factors in the development and progression of graft arteriosclerosis: preliminary insights from a multicenter intravascular ultrasound study. J Heart Lung Transplant 1995;14:S238-42.
23. Day JD, Rayburn Bk, Gaudin PB, et al. Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury. J Heart Lung Transplant 1995;14:S142-49.
24. Zerbe TR, Kormos RL, Uretsky B, Griffith BP, Hardesty RL, Dusquesnoy RJ. Cardiac obliterative arteriopathy: impact of cellular rejection and donor factors. J Heart Lung Transplant 1992;11:193.
25. Baldwin JC, Anderson JL, Boucek MM, et al. Twenty-fourth Bethesda conference. Task force 2: donor guidelines. J Am Coll Cardiol 1993;22:15-20.
26. Oakley RME, Yonan NA, Simpson BM, Deiraniya AK. Extended criteria for cardiac allograft donors: a consensus study. J Heart Lung Transplant 1996;15:255-9.
27. Laks H, Gates RN, Ardehali A, et al. Orthotopic heart transplantation and concurrent coronary bypass. J Heart Lung Transplant 1993;12:810-5.
28. Drinkwater DC, Laks H, Blitz A, et al. Outcomes of patients undergoing transplantation with older donor hearts. J Heart Lung Transplant 1996;15:684-91.
29. Hebert MJ, Boucher A, Beaucage G, Girard R, Dandavino R. Transplantation of kidneys from a donor with carbon monoxide poisoning. N Engl J Med 1992;32:1571.
30. Barkoukis TJ, Sarback CA, Lewis D, Whittier FC. Multiorgan procurement from a victim of cyanide poisoning: a case report and review of the literature. Transplantation 1993;55: 1434-6.
31. Freidlander MM, Rosenmann E, Rubinger D, et al. Successful renal transplantation from two donors with methanol intoxication. Transplantation 1996;61:1549-52.
32. Kron IL, Tribble CG, Kern JA, et al. Successful transplantation of marginally acceptable thoracic organs. Ann Surg 1993;217:518-24.
33. Laks H, Scholl FG, Drinkwater DC, et al. The alternate recipient list for heart transplantation: does it work? J Heart Lung Transplant 1997;16:735-42.
34. Boucek MM, Mathis CM, Kanakriyeh MS, et al. Donor shortage: use of the dysfunctional donor heart. J Heart Transplant 1993;12:S186-90.
35. Kawauchi M, Gundry SR, deBegona JA, Razzouk AJ, Bailey LL. Utilization of pediatric donors salvaged by cardiopulmonary resuscitation. J Heart Lung Transplant 1993;12:185-8.
36. Wheeldon DR, Potter CDO, Odura A, Wallwork J, Large SR. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995;14:734-42.
37. Novitzky D, Cooper DK, Chaffin JS, Greer AE, DeBault LE, Zuhdi N. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990;49:311-6.
38. Jeevandandam V, Todd B, Regillo T, Hellman S, Eldridge C, McClurken J. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant 1994;13:681-7.
39. Milano A, Livi U, Casula R, et al. Influence of marginal donors on early results after heart transplantation. Transplant Proc 1993;25:3158-9.
40. Livi U, Faggian G, Chiominto B, Mazzucco A, Bortolott U, Gallucci V. Heterotopic heart transplantation: a means to increase donor availability. Eur J Cardiothorac Surg 1990;4: 202-6.
41. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ. The registry of the International Society for Heart and Lung Transplantation: 14th official report - 1997. J Heart Lung Transplant 1997;16:691-712.
42. Breen TJ, Keck B, Daily OP, Hosenpud JD. The use of older donors results in a major increase in early mortality following orthotopic cardiac transplantation. XVI World Congress of the Transplantation Society Kyoto, Japan. Book of Abstracts. Abstract number 420.
43. Pierson RN, Reed GW. Short and intermediate-term implications of using older donors for heart transplantation. XVI International Congress of the Transplantation Society Kyoto, Japan. Book of Abstracts 1996. Abstract number 123.
44. Renlund DG, Talyor DO, Ensley D, et al. Exercise capacity after heart transplantation: influence of donor and recipient characteristics. J Heart Lung Transplant 1996;15:16-24.
45. Piccolo G, Cardillo M, Scalamogna M, Pizzi C, Porta E, Sirchia G. Influence of donor age on recipient survival after heart transplantation. 8th Congress of the European Society for Organ Transplantation (ESOT), 1997. Abstract number 102:67.
46. St. Goar FG, Pinto FJ, Alderman EL, et al. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of angiographically silent intimal thickening. Circulation 1992;85:756-63.
47. Schueler S, Matschke K, Loebe M, Hummenl M, Fleck E, Hetzer R. Coronary artery disease in patients with hearts from older donors: morphologic features and therapeutic implications. J Heart Lung Transplant 1993;12:100-9.
48. Tuzcu ME, Hobbs RE, Rincon G, et al. Occult and frequent transmission of atherosclerotic coronary artery disease with cardiac transplantation. Insights from intravascular ultrasound. Circulation 1995;91:1706-13.
49. Botas J, Pinto FJ, Chenzbraun A, et al. Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy. An intravascular ultrasound study. Circulation 1995;92:1126-32.
50. Penn I. Donor transmitted disease: cancer. Transplant Proc 1991;23:2629-31.
51. Loh E, Couch FJ, Hendrickson C, et al. Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation. JAMA 1997;277:133-55.
52. Bennett LE, Edwards EB, Daily OP, Hosenpud JD. Does the benefit of transplantation for presumed "stable" recipients of older donor hearts outweigh the risk of remaining on the waiting list? XVI International Congress of the Transplantation Society Kyoto, Japan. Book of Abstracts 1996. Abstract number 124.
53. Jacobbi LM, McBridge V, Etheredge EE, et al. The risks, benefits and costs of expanding donor criteria. Transplantation 1995;60:1491-6.
54. Schueler S, Parnt H, Warnecke H, Matheis G, Hetzer R. Extended criteria for heart transplantation. J Heart Lung Transplant 1988;7:326-30.
55. Mulvagh SL, Thornton B, Frazier OH, et al. The older cardiac transplant donor: relation to graft function and recipient survival longer than 6 years. Circulation 1989; 80(suppl):III126-32.
56. Schueler S, Warnecke H, Loebe M, Fleck E, Hetzer R. Extended donor age in heart transplantation. Circulation 1989;80(suppl):III133-9.
57. Menkis A, Novick RJ, Kostuk WJ, et al. Successful use of the "unacceptable" heart donor. J Heart Lung Transplant 1991; 10:28-32.
58. Luciani GB, Livi U, Fggian G, Chiomento B, Bortolotti U, Mazzucco A. Heart transplantation with donors over 40 years of age. Transplant Proc 1991;23:2596-7.
59. Pflugfelder PW, Singh NR, McKenzie FN, Menkis AH, Novick RJ, Kostuk WJ. Extending cardiac allograft ischemic time and donor age: effect on survival and long-term cardiac function. J Heart Lung Transplant 1991;10:394-400.
60. Livi U, Bortolotti U, Luciani GB, et al. Donor shortage in heart transplantation. Is extension of donor age limits justified? J Thorac Cardiovasc Surg 1994;107:1346-55.
61. Livi U, Caforio ALP, Tursi V, et al. Donor age greater than 50 years does not influence mid-term results of heart transplantation. Transplant Proc 1996;28:91-2.